Navigation Links
North Dakota Grants Enova Medical Technologies a $2.5 Million Centers of Excellence Grant
Date:11/8/2007

ce Research, Development and Commercialization is to provide the research, development, and commercialization resources for a range of biomedical devices. Over time, the Center will conduct multiple, concurrent projects for various biomedical companies and cities, thereby providing the potential for economic development throughout North Dakota and the region.

Enova Medical Technologies, a privately-held company, is engaged in the development and commercialization of proprietary medical devices and is an experienced provider of product development, manufacturing, and commercialization services for the medical device industry. From Class I to Class III devices, Enova understands the technical challenges of product design, engineering, research and development, the regulatory steps required to successfully commercialize products, and the marketing and sales efforts needed to move inventory off the shelf. For more information, visit http://www.enovamedical.com.


'/>"/>
SOURCE Enova Medical Technologies
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Novo Nordisk Appoints New Leader of North American Business
2. Health IT Event Draws Experts to the Pacific Northwest
3. Revolutionary HD Surgical Footage from North Shore-LIJ Surgeon to be Broadcast for the First Time on ABCs 20/20, National Geographic Channel
4. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
5. Evanston Northwestern Healthcare Wins Award For Patient Safety
6. Physician Team at Northwestern Memorial Performs Rare Oral Gallbladder Removal
7. Northstar Healthcare Announces Option to Purchase a 60% Interest in The Palladium for Surgery - Dallas
8. Dermatologists identify North Texas leishmaniasis outbreak
9. Radiation Therapy Services Acquires North Carolina Facility
10. Northern Michigan Regional Health System Named a Working Mother 100 Best Company - 2007 by Working Mother Magazine
11. NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ced Acquisition in 2009 Continues Growth Trend , ...rstCall/ -- IPC The Hospitalist Company, Inc. (Nas...ician group practice company, announced today that...st Acute Care Consultants, Inc. (MACC) in St. Loui...expansion in the St. Louis market, where IPC has e...
(Date:1/8/2009)...Jan. 8 The Pew Charitab...een named director, chemical and food safety progr...gram. Olson, who was formerly deputy staff directo...nvironment and Public Works, brings nearly 25 year...er advocacy to Pew. , , "We are excited to be ...
(Date:1/8/2009)... Jan. 8 Cephalon, Inc ....ino, Jr., Ph.D., Chairman and CEO will present at... on January 13, 2009 in San Francisco, CA at appro...me). The presentation will be webcast live on the ...e. , , The webcast will be archived for one we...
(Date:1/8/2009)...lo., Jan. 8 Heska Corpor...bcast: , , , What: Heska Corporation I... Year-End 2008 Earnings Conference Call on t...:00 a.m. (MST], Where: www.heska.com (cli... Call link on the front page of this website)....
Breaking Medicine News(10 mins):Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2
...nvolving more than 65, 000 persons show a positi... the risk of developing cancer//. Dr. Par Stattin...m, who examined data from 31,304 men and 33,293 wo...cts had previously participated in a larger study...
...change in health caused by an unintentional injury... are more likely to have difficulty// obtaining re...ce larger declines in short-term health, according...he Urban Institute, Washington, D.C., presented th...
...le phones when the ban on them gets lifted shortly...s because it was believed// that its electromagnet...al equipments. But as per the directive issued fro...d everywhere excepting near a few specialist equip...
...om the Centers for Disease Control// and Preventio...atistics have decreased significantly in their cou... this mainly to routine hepatitis immunizations, i...reports that more than 100,000 Americans were infe...
Other Medicine News:Health News:Beware of High Sugar Levels Even If You are Not Diabetic 2Health News:Uninsured Often Receive Less Medical Care 2Health News:Hepatitis Rates Plummet in the U.S 2
(Date:1/7/2009)...tan Puhua Hospital Stem Cells Center ( http://www....g stem cells to effectively treat neurological dis...ed additions to its medical and research staff tha...pabilities for growing numbers of incoming interna...e distinguished Dr. Jiang Ping, who was named Chie...
(Date:1/6/2009)...ire/ -- The Michael J. Fox Foundation awarded a to...h teams for pre-clinical research on potential new...nding was awarded under the Foundation,s Therapeu...launched in 2006, supports and bolsters industry-f...art of MJFF,s focus on ,de-risking, preclinical ...
(Date:1/5/2009)...lene Pharmaceuticals announced today that it has i...protein kinase inhibitor, CX-4945, in patients wit...ultiple myeloma. The primary endpoints of the oral..., tolerance and PK properties of CX-4945 and to se...addition, multiple mechanism-related pharmacodynam...
(Date:12/29/2008)...SNewswire/ -- The winner of the 2008 Award for Exc... today by Dr. Peter G. Goldschmidt, President and ..., The winner of the annual award was the Unive...or its best practice " IND Regulatory and Monitori...d human subjects protection, 2) improved data qual...
Breaking Medicine Technology:Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 32008 Human Research Protection Award Recipients Announced 2Few Employers Addressing Workplace Stress Watson Wyatt Surveys Find 11948 1Few Employers Addressing Workplace Stress Watson Wyatt Surveys Find 11948 2Few Employers Addressing Workplace Stress Watson Wyatt Surveys Find 11948 3Strategy for nanotechnology related environmental health and safety research 2209 1Strategy for nanotechnology related environmental health and safety research 2209 2IAEA helps recover stray radioactive sources in Nigeria 2204 1IAEA helps recover stray radioactive sources in Nigeria 2204 2DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 11941 1DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 11941 2DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 11941 3
...r 18, 2007 - Nymox,Pharmaceutical Corporation (NAS...month follow-up study of NX-1207 for benign,prosta...atic,progress of U.S. patients involved in the Com...dividuals in the study were assessed,for symptomat... of,efficacy. Patients in the study were assessed ...
...WIRE)--Apr 17, 2007 -,Seattle Genetics, Inc. (Nasd...tations by the company and its collaborators at th...for Cancer Research,(AACR) demonstrating preclinic...jugate (ADC) technology and cancer product,pipelin...killing drugs.,Seattle Genetics, ADC technology em...
Other Medicine Technology:Nymox Reports Completion of New 42 Month Follow-up Study of NX-1207,for BPH 2Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 2Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 3Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 4
If you prefer a standard style iridectomy lens, then consider the Volk Iridectomy Lens. Its 8mm imaging bulb delivers the view you're used to but with the added benefit of Volk's exclusive Double Asp
...d Super Macula® 2.2 offers extremely high reso...vea, while achieving an exceptionally wide 78°...or critical evaluation of the optic nerve head and...f the macula and disc. Redesigned to reduce weight...
...Equator is designed for focal laser therapy and mi...ptical design presents a realistic contour of the ...ld view of the entire posterior pole extending to ...ws dynamic movement on the globe, therefore increa...
...0x Imaging Lens is optimized for the visible spect...ns during general diagnosis and slit lamp imaging....posterior pole and a sharper image across the diam...s also ideal for slit lamp photography. For best r...
Medicine Products: